Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Canadian Cancer Trials Group
European Organisation for Research and Treatment of Cancer - EORTC
Aura Biosciences
Immunocore Ltd
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
IDEAYA Biosciences
University of Sao Paulo
NRG Oncology
Philogen S.p.A.
Karolinska University Hospital
ETOP IBCSG Partners Foundation
Soligenix
Aresus Pharma GmbH
UNICANCER
St. Erik Eye Hospital
University of Aarhus
Women's College Hospital
University of Utah
Vastra Gotaland Region